Inventor
NARLA RAMA K
US15 patents
⚠️ This page may combine multiple inventors who share the name “NARLA RAMA K”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SIGNAL PHARM LLC
5 patentsUS9493466B2Nov 15, 2016
Treatment of cancer with TOR kinase inhibitors
SIGNAL PHARM LLC7 citations83
US11166950B2Nov 9, 2021
Treatment of cancer with TOR kinase inhibitors
SIGNAL PHARM LLC0 citations62
US9937170B2Apr 10, 2018
Treatment of cancer with TOR kinase inhibitors
SIGNAL PHARM LLC1 citations62
US10391092B2Aug 27, 2019
Methods for treating cancer using dihydropyrazino-pyrazine compound combination therapy
SIGNAL PHARM LLC0 citations51
US9937169B2Apr 10, 2018
Methods for treating cancer using dihydropyrazino-pyrazine compound combination therapy
SIGNAL PHARM LLC0 citations51
PERRIN-NINKOVIC SOPHIE
3 patentsUS8492381B2Jul 23, 2013
Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway
PERRIN-NINKOVIC SOPHIE44 citations95
US8110578B2Feb 7, 2012
Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway
PERRIN-NINKOVIC SOPHIE67 citations95
US8507492B2Aug 13, 2013
Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/AKT pathway
PERRIN-NINKOVIC SOPHIE22 citations90
SIGNAL PHARMACEUTICAL LLC
3 patentsUS9428509B2Aug 30, 2016
Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith
SIGNAL PHARMACEUTICAL LLC6 citations81
US9346812B2May 24, 2016
Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith
SIGNAL PHARMACEUTICAL LLC6 citations81
US9795607B2Oct 24, 2017
Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith
SIGNAL PHARMACEUTICAL LLC0 citations49
PARKER HUGHES INST
3 patentsUS6797721B2Sep 28, 2004
Phorboxazole derivatives for treating cancer
PARKER HUGHES INST4 citations55
US6794541B2Sep 21, 2004
Thiourea and urea liquid-phase combinatorial libraries: synthesis and apoptosis induction
PARKER HUGHES INST0 citations47
US6737537B2May 18, 2004
Platinum (II) antitumor compounds
PARKER HUGHES INST0 citations40